[Clinical aspects of primary myelofibrosis in Japan]

Rinsho Ketsueki. 2014 Mar;55(3):289-94.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Blood Cell Count
  • Danazol / therapeutic use
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Hydroxyurea / therapeutic use
  • Japan
  • Methenolone / analogs & derivatives
  • Methenolone / therapeutic use
  • Palliative Care
  • Prednisolone / therapeutic use
  • Primary Myelofibrosis* / blood
  • Primary Myelofibrosis* / mortality
  • Primary Myelofibrosis* / physiopathology
  • Primary Myelofibrosis* / therapy
  • Prognosis
  • Radiotherapy / methods
  • Spleen
  • Survival Rate
  • Transplantation Conditioning

Substances

  • Methenolone
  • Prednisolone
  • Danazol
  • methenolone acetate
  • Hydroxyurea